microRNAs are important regulators of cell processes and have been proposed as potential
preeclampsia biomarkers. We evaluated serum microRNA expression profiling to identify …

The present study aimed to identify the differential expression profiles of microRNAs in the
plasma between patients with preeclampsia (PE) and healthy pregnancies using …

Abstract Objective To identify microRNAs (miRNAs) differentially expressed at early stages
of gestation (12–14 weeks) in the serum of pregnant women, who later developed severe …

Until recently, the molecular pathogenesis of preeclampsia (PE) remained largely unknown.
Reports have shown that circulating microRNAs (miRNAs) are promising novel biomarkers …

MicroRNAs (miRNAs) play an important role in the pathophysiology of preeclampsia (PE).
However, the expression of circulating miRNAs was not analyzed in the second trimester of …

To assess the usefulness of circulating microRNAs (miRNAs) as non-invasive molecular
biomarkers for early prediction of preeclampsia, a differential miRNA profiling analysis was …

Preeclampsia is a common disease in pregnant women that can only be diagnosed from 20
weeks after fertilization. Developing early diagnosis markers is urgent and would be helpful …

OBJECTIVE: The purpose of this study was to perform a comprehensive analysis of the
microRNA expression profile in placentas from preeclamptic pregnancies vs normal …

Preeclampsia is a pregnancy complication associated with angiogenic dysbalance,
maternal endothelial dysfunction and end-organ injury. A predictive test to identify those who …

Preeclampsia (PE) is a pregnancy syndrome characterized by hypertension and proteinuria,
and a leading cause of maternal and fetal morbidity and mortality, with poorly defined …